Small molecule · Agonist of retinoic acid receptor alpha (RARA), retinoic acid receptor beta (RARB) and retinoic acid receptor gamma (RARG) · developed by Bausch
ApprovedFDA, Jul 1974
1Registered trials
What is Tretinoin?
Tretinoin is a metabolite of vitamin A that binds retinoic acid receptors RARα, RARβ and RARγ in the cytosol and nucleus, modifying gene expression and epithelial cell growth and differentiation. It is applied topically to reduce follicular epithelial cohesiveness and comedone formation in acne vulgaris.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Oct 14, 2026). Read the full label for the exact wording, limitations and safety information.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.